Financhill
Sell
49

ILMN Quote, Financials, Valuation and Earnings

Last price:
$83.17
Seasonality move :
3.93%
Day range:
$82.07 - $83.91
52-week range:
$68.70 - $156.66
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
3.05x
P/B ratio:
5.56x
Volume:
1.4M
Avg. volume:
2.1M
1-year change:
-16.37%
Market cap:
$13.2B
Revenue:
$4.4B
EPS (TTM):
-$6.07

Price Performance History

Performance vs. Valuation Benchmarks

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Competitors

Company Revenue Forecast Earnings Forecast Revenue Growth Forecast Earnings Growth Forecast Analyst Price Target Median
ILMN
Illumina
$1B $0.94 -5.72% 430.2% $106.53
CTSO
CytoSorbents
$9M -$0.07 10.68% -41.38% $5.00
DCTH
Delcath Systems
$16.8M $0.03 194.07% -93.78% $24.08
DHR
Danaher
$5.6B $1.64 1.5% 34.41% $247.35
EXAS
Exact Sciences
$688.6M -$0.10 10.52% -84.17% $68.87
STRR
Star Equity Holdings
$16.4M -$0.25 24.23% -43.28% $8.50
Company Price Analyst Target Market Cap P/E Ratio Dividend per Share Dividend Yield Price / LTM Sales
ILMN
Illumina
$83.16 $106.53 $13.2B -- $0.00 0% 3.05x
CTSO
CytoSorbents
$1.00 $5.00 $62.6M -- $0.00 0% 1.58x
DCTH
Delcath Systems
$16.38 $24.08 $570.5M -- $0.00 0% 10.06x
DHR
Danaher
$193.08 $247.35 $138.2B 37.49x $0.32 0.59% 5.92x
EXAS
Exact Sciences
$55.17 $68.87 $10.4B -- $0.00 0% 3.62x
STRR
Star Equity Holdings
$2.20 $8.50 $7.1M 0.75x $0.00 0% 0.12x
Company Total Debt / Total Capital Beta Debt to Equity Quick Ratio
ILMN
Illumina
45.66% 1.567 15.77% 1.34x
CTSO
CytoSorbents
49.38% 0.020 22.69% 1.98x
DCTH
Delcath Systems
-- 2.956 -- 13.86x
DHR
Danaher
24.47% 0.156 11.23% 0.83x
EXAS
Exact Sciences
49.21% 1.742 28.45% 2.12x
STRR
Star Equity Holdings
18.39% 0.331 40.47% 0.69x
Company Gross Profit Operating Income Return on Invested Capital Return on Common Equity EBIT Margin Free Cash Flow
ILMN
Illumina
$683M $164M -20.34% -34.38% 19.89% $201M
CTSO
CytoSorbents
$6.2M -$3.9M -58.93% -106.57% -10.01% -$3.5M
DCTH
Delcath Systems
$16.9M $642K -37.34% -40.28% 3.25% $2.1M
DHR
Danaher
$3.5B $1.3B 5.53% 7.38% 20.92% $1.1B
EXAS
Exact Sciences
$500.5M -$89.8M -19.08% -35.57% -13.04% -$365K
STRR
Star Equity Holdings
$3.1M -$2.8M -13.58% -15.99% -22.03% $200K

Illumina vs. Competitors

  • Which has Higher Returns ILMN or CTSO?

    CytoSorbents has a net margin of 12.58% compared to Illumina's net margin of -16.94%. Illumina's return on equity of -34.38% beat CytoSorbents's return on equity of -106.57%.

    Company Gross Margin Earnings Per Share Invested Capital
    ILMN
    Illumina
    65.61% $0.82 $4.4B
    CTSO
    CytoSorbents
    71.13% -$0.02 $28.7M
  • What do Analysts Say About ILMN or CTSO?

    Illumina has a consensus price target of $106.53, signalling upside risk potential of 28.1%. On the other hand CytoSorbents has an analysts' consensus of $5.00 which suggests that it could grow by 400%. Given that CytoSorbents has higher upside potential than Illumina, analysts believe CytoSorbents is more attractive than Illumina.

    Company Buy Ratings Hold Ratings Sell Ratings
    ILMN
    Illumina
    7 11 0
    CTSO
    CytoSorbents
    1 1 0
  • Is ILMN or CTSO More Risky?

    Illumina has a beta of 1.324, which suggesting that the stock is 32.43% more volatile than S&P 500. In comparison CytoSorbents has a beta of 1.046, suggesting its more volatile than the S&P 500 by 4.577%.

  • Which is a Better Dividend Stock ILMN or CTSO?

    Illumina has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. CytoSorbents offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Illumina pays -- of its earnings as a dividend. CytoSorbents pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios ILMN or CTSO?

    Illumina quarterly revenues are $1B, which are larger than CytoSorbents quarterly revenues of $8.7M. Illumina's net income of $131M is higher than CytoSorbents's net income of -$1.5M. Notably, Illumina's price-to-earnings ratio is -- while CytoSorbents's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Illumina is 3.05x versus 1.58x for CytoSorbents. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    ILMN
    Illumina
    3.05x -- $1B $131M
    CTSO
    CytoSorbents
    1.58x -- $8.7M -$1.5M
  • Which has Higher Returns ILMN or DCTH?

    Delcath Systems has a net margin of 12.58% compared to Illumina's net margin of 5.4%. Illumina's return on equity of -34.38% beat Delcath Systems's return on equity of -40.28%.

    Company Gross Margin Earnings Per Share Invested Capital
    ILMN
    Illumina
    65.61% $0.82 $4.4B
    DCTH
    Delcath Systems
    85.62% $0.03 $80.2M
  • What do Analysts Say About ILMN or DCTH?

    Illumina has a consensus price target of $106.53, signalling upside risk potential of 28.1%. On the other hand Delcath Systems has an analysts' consensus of $24.08 which suggests that it could grow by 47%. Given that Delcath Systems has higher upside potential than Illumina, analysts believe Delcath Systems is more attractive than Illumina.

    Company Buy Ratings Hold Ratings Sell Ratings
    ILMN
    Illumina
    7 11 0
    DCTH
    Delcath Systems
    4 0 0
  • Is ILMN or DCTH More Risky?

    Illumina has a beta of 1.324, which suggesting that the stock is 32.43% more volatile than S&P 500. In comparison Delcath Systems has a beta of 0.948, suggesting its less volatile than the S&P 500 by 5.238%.

  • Which is a Better Dividend Stock ILMN or DCTH?

    Illumina has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Delcath Systems offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Illumina pays -- of its earnings as a dividend. Delcath Systems pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios ILMN or DCTH?

    Illumina quarterly revenues are $1B, which are larger than Delcath Systems quarterly revenues of $19.8M. Illumina's net income of $131M is higher than Delcath Systems's net income of $1.1M. Notably, Illumina's price-to-earnings ratio is -- while Delcath Systems's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Illumina is 3.05x versus 10.06x for Delcath Systems. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    ILMN
    Illumina
    3.05x -- $1B $131M
    DCTH
    Delcath Systems
    10.06x -- $19.8M $1.1M
  • Which has Higher Returns ILMN or DHR?

    Danaher has a net margin of 12.58% compared to Illumina's net margin of 16.62%. Illumina's return on equity of -34.38% beat Danaher's return on equity of 7.38%.

    Company Gross Margin Earnings Per Share Invested Capital
    ILMN
    Illumina
    65.61% $0.82 $4.4B
    DHR
    Danaher
    61.16% $1.32 $67.3B
  • What do Analysts Say About ILMN or DHR?

    Illumina has a consensus price target of $106.53, signalling upside risk potential of 28.1%. On the other hand Danaher has an analysts' consensus of $247.35 which suggests that it could grow by 28.11%. Given that Danaher has higher upside potential than Illumina, analysts believe Danaher is more attractive than Illumina.

    Company Buy Ratings Hold Ratings Sell Ratings
    ILMN
    Illumina
    7 11 0
    DHR
    Danaher
    19 3 0
  • Is ILMN or DHR More Risky?

    Illumina has a beta of 1.324, which suggesting that the stock is 32.43% more volatile than S&P 500. In comparison Danaher has a beta of 0.772, suggesting its less volatile than the S&P 500 by 22.765%.

  • Which is a Better Dividend Stock ILMN or DHR?

    Illumina has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Danaher offers a yield of 0.59% to investors and pays a quarterly dividend of $0.32 per share. Illumina pays -- of its earnings as a dividend. Danaher pays out 19.7% of its earnings as a dividend. Danaher's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

  • Which has Better Financial Ratios ILMN or DHR?

    Illumina quarterly revenues are $1B, which are smaller than Danaher quarterly revenues of $5.7B. Illumina's net income of $131M is lower than Danaher's net income of $954M. Notably, Illumina's price-to-earnings ratio is -- while Danaher's PE ratio is 37.49x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Illumina is 3.05x versus 5.92x for Danaher. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    ILMN
    Illumina
    3.05x -- $1B $131M
    DHR
    Danaher
    5.92x 37.49x $5.7B $954M
  • Which has Higher Returns ILMN or EXAS?

    Exact Sciences has a net margin of 12.58% compared to Illumina's net margin of -14.32%. Illumina's return on equity of -34.38% beat Exact Sciences's return on equity of -35.57%.

    Company Gross Margin Earnings Per Share Invested Capital
    ILMN
    Illumina
    65.61% $0.82 $4.4B
    EXAS
    Exact Sciences
    70.82% -$0.54 $4.7B
  • What do Analysts Say About ILMN or EXAS?

    Illumina has a consensus price target of $106.53, signalling upside risk potential of 28.1%. On the other hand Exact Sciences has an analysts' consensus of $68.87 which suggests that it could grow by 24.82%. Given that Illumina has higher upside potential than Exact Sciences, analysts believe Illumina is more attractive than Exact Sciences.

    Company Buy Ratings Hold Ratings Sell Ratings
    ILMN
    Illumina
    7 11 0
    EXAS
    Exact Sciences
    18 4 0
  • Is ILMN or EXAS More Risky?

    Illumina has a beta of 1.324, which suggesting that the stock is 32.43% more volatile than S&P 500. In comparison Exact Sciences has a beta of 0.977, suggesting its less volatile than the S&P 500 by 2.282%.

  • Which is a Better Dividend Stock ILMN or EXAS?

    Illumina has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Exact Sciences offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Illumina pays -- of its earnings as a dividend. Exact Sciences pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios ILMN or EXAS?

    Illumina quarterly revenues are $1B, which are larger than Exact Sciences quarterly revenues of $706.8M. Illumina's net income of $131M is higher than Exact Sciences's net income of -$101.2M. Notably, Illumina's price-to-earnings ratio is -- while Exact Sciences's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Illumina is 3.05x versus 3.62x for Exact Sciences. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    ILMN
    Illumina
    3.05x -- $1B $131M
    EXAS
    Exact Sciences
    3.62x -- $706.8M -$101.2M
  • Which has Higher Returns ILMN or STRR?

    Star Equity Holdings has a net margin of 12.58% compared to Illumina's net margin of -9.1%. Illumina's return on equity of -34.38% beat Star Equity Holdings's return on equity of -15.99%.

    Company Gross Margin Earnings Per Share Invested Capital
    ILMN
    Illumina
    65.61% $0.82 $4.4B
    STRR
    Star Equity Holdings
    24.27% -$0.52 $73.2M
  • What do Analysts Say About ILMN or STRR?

    Illumina has a consensus price target of $106.53, signalling upside risk potential of 28.1%. On the other hand Star Equity Holdings has an analysts' consensus of $8.50 which suggests that it could grow by 286.36%. Given that Star Equity Holdings has higher upside potential than Illumina, analysts believe Star Equity Holdings is more attractive than Illumina.

    Company Buy Ratings Hold Ratings Sell Ratings
    ILMN
    Illumina
    7 11 0
    STRR
    Star Equity Holdings
    1 0 0
  • Is ILMN or STRR More Risky?

    Illumina has a beta of 1.324, which suggesting that the stock is 32.43% more volatile than S&P 500. In comparison Star Equity Holdings has a beta of 1.002, suggesting its more volatile than the S&P 500 by 0.203%.

  • Which is a Better Dividend Stock ILMN or STRR?

    Illumina has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Star Equity Holdings offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Illumina pays -- of its earnings as a dividend. Star Equity Holdings pays out -19.54% of its earnings as a dividend.

  • Which has Better Financial Ratios ILMN or STRR?

    Illumina quarterly revenues are $1B, which are larger than Star Equity Holdings quarterly revenues of $12.9M. Illumina's net income of $131M is higher than Star Equity Holdings's net income of -$1.2M. Notably, Illumina's price-to-earnings ratio is -- while Star Equity Holdings's PE ratio is 0.75x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Illumina is 3.05x versus 0.12x for Star Equity Holdings. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    ILMN
    Illumina
    3.05x -- $1B $131M
    STRR
    Star Equity Holdings
    0.12x 0.75x $12.9M -$1.2M

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is It Time to Sell MercadoLibre?
Is It Time to Sell MercadoLibre?

MercadoLibre (NASDAQ:MELI) has earned a reputation for being not dissimilar…

Is Tesla Stock High Risk or High Reward?
Is Tesla Stock High Risk or High Reward?

EV-making supergiant Tesla, Inc. (NASDAQ:TSLA) is going through a difficult…

Why Did Chase Coleman Buy TSM?
Why Did Chase Coleman Buy TSM?

Billionaire Chase Coleman of Tiger Global Management has built a…

Stock Ideas

Buy
65
Is NVDA Stock a Buy?

Market Cap: $3.5T
P/E Ratio: 48x

Buy
67
Is MSFT Stock a Buy?

Market Cap: $3.4T
P/E Ratio: 39x

Sell
42
Is AAPL Stock a Buy?

Market Cap: $3T
P/E Ratio: 33x

Alerts

Buy
80
GWRE alert for Jun 5

Guidewire Software [GWRE] is up 16.33% over the past day.

Buy
60
REVG alert for Jun 5

REV Group [REVG] is up 15.05% over the past day.

Buy
55
SIG alert for Jun 5

Signet Jewelers [SIG] is down 0.96% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock